BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29350398)

  • 1. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
    Lippmann C; Kringel D; Ultsch A; Lötsch J
    Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
    El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
    Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
    [No Abstract]   [Full Text] [Related]  

  • 9. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
    Wang H; Gu Q; Wei J; Cao Z; Liu Q
    Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Prediction of Drug-Target Interactions via Ensemble Learning.
    Ezzat A; Wu M; Li X; Kwoh CK
    Methods Mol Biol; 2019; 1903():239-254. PubMed ID: 30547446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy.
    Lötsch J; Ultsch A
    CPT Pharmacometrics Syst Pharmacol; 2016 Apr; 5(4):192-200. PubMed ID: 27069773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A machine-learned computational functional genomics-based approach to drug classification.
    Lötsch J; Ultsch A
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1449-1461. PubMed ID: 27695919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
    Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
    Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
    Shao M; Jiang L; Meng Z; Xu J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.